ENOB News and Press, Enochian Biosciences Inc. From 06/18/21

Shares of Enochian Biosciences Inc. (NASDAQ:ENOB) traded at a new 52-week high today of $6.17. Approximately 15.1 million shares have changed hands today, as compared to an average 30-day volume of 127,000 shares. Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in ...

Shares of Enochian Biosciences Inc. (NASDAQ:ENOB) traded today at $6.09, eclipsing its 52-week high. This new high was reached on above average trading volume as 15.1 million shares traded hands, while the average 30-day volume is approximately 127,000 shares. In the past 52 weeks, share...

Pioneering Research Institute In Los Angeles Moves One Step Closer To Finding A Cure For HIV Promising Treatment Using Cell Therapy Moves to First Stage of FDA Approval Process PR Newswire LOS ANGELES , June 15, 2021 /PRNewswire/ -- (NASDAQ: ENOB) &...

peshkov/iStock via Getty Images Bitcoin (BTC-USD) received a boost on Monday thanks to comments from a couple of heavy hitters. Both Elon Musk and Paul Tudor Jones made remarks that goosed the cryptocurrency. Investors got some macro insight from a couple of top minds in the financial industr...

Shares of Enochian BioSciences (NASDAQ: ENOB) soared on Monday after the biopharmaceutical company said the Food and Drug Administration (FDA) accepted its pre-investigational new drug request for a "potential functional cure" of HIV. As of 2:45 p.m. EDT, the biotech stock's pri...

LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it has entered into a definitive securities purchase agreement with seve...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Enochain Biosciences (NASDAQ: ENOB ) stock are blasting off on Monday after great news emerged for the biotechnology company from the U.S. Food and Drug Administration (FDA). Source: Shutterstock Acc...

Gainers: Enochian Biosciences ENOB +127%, RAPT Therapeutics RAPT +101%, iTeos Therapeutics ITOS +37%, Novan NOVN +30%, Anavex Life Sciences AVXL +23%.Losers: Avenue Therapeutics ATXI -39%, Inhibikase Therapeutics (IKT) -21%, ...

Best Penny Stocks to Watch This Week With another week of trading penny stocks upon us, which companies are investors watching this week? Well, it’s hard to say for certain, but we can always use current events to help guide our penny stocks watchlists . Over the past wee...

Enochian BioSciences (ENOB) shares skyrocket to more than double their value during the premarket session after the U.S. FDA accepted a Pre-IND ((Investigational New Drug)) request for a potential functional cure or treatment of HIV.The request was based on the results of a 54-year old man li...